Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

The private for-profit sector is an important source of treatment for malaria. However, private patients face high prices for the recommended treatment for uncomplicated malaria, artemisinin combination therapies (ACTs), which makes them more likely to receive cheaper, less effective non-artemisinin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Health Policy Plan
Päätekijät: Palafox, Benjamin, Patouillard, Edith, Tougher, Sarah, Goodman, Catherine, Hanson, Kara, Kleinschmidt, Immo, Torres Rueda, Sergio, Kiefer, Sabine, O’Connell, Kate, Zinsou, Cyprien, Phok, Sochea, Akulayi, Louis, Arogundade, Ekundayo, Buyungo, Peter, Mpasela, Felton, Poyer, Stephen, Chavasse, Desmond
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2016
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://ncbi.nlm.nih.gov/pubmed/25944705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/heapol/czv031
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia